comparison the protective effect of mucosal bcg vaccination with subcutaneous against leishmania major infection in susceptible balb/c mice

Authors
abstract

introduction: study the protective effect of mucosal bcg vaccination with subcutaneous against leishmania major infection in susceptible balb/c mice material and methods: 6-8 weeks old male balb/c mice,were divided to two test groups and four control groups of 20 of mice and then vaccinated. two test groups vaccinated with appropriate dose of bcg through rectal and subcutaneous routs. they vaccinated one month later with alm+alum subcutaneously. after receiving the booster dose (21 days later), mice challenged with the injection of 105 leishmania major in the hind footpad and lesion development evaluated every week. immunologic responses like, delayed type hypersensitivity to purified protein derivatives (ppd), splenocytes proliferation and ifn-γ and il-5 cytokine production measured in the supernatant of splenocytes culture. control groups were those that received only alm+alum or only alum adjuvant subcutaneously. another control groups challenged with leishmania without any vaccination or were kept as environmental control without any treatment. results: stimulatory effect of bcg on immune system observed in both groups of vaccination according to significant increase (p≤0.05) in delayed type hypersensitivity and ifn-γ production response. increase in splenocytes proliferation observed up to three weeks after challenge. but after that, bcg vaccinated groups had a lot of variations in immune response that finally tend to disease overcome in subcutaneously bcg vaccinated group. the main reason was the significant decrease in ifn-γ production and splenocytes proliferation to rectal group .parasite dissemination in lymphoid organs were increased significantly in comparison with rectal immunized group. in a different way rectal immunized group showed a high resistant to infection by increase and maintenance of anti-leishmania responses. conclusion: rectal bcg vaccination can induce more stable cellular immune response in comparison to subcutaneous vaccination and make animals protective, by inhibition of l. major dissemination.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Role of imiquimod as adjuvant for vaccination against Leishmania major infection in BALB/c mice

Various adjuvants in combination with different antigens have been utilized as a vaccine candidate against leishmaniasis. However, the search for ideal adjuvants is still pursued due to the inefficiencies of current compounds. In the present study, the effect of imiquimod, as an adjuvant, is studied with soluble Leishmania antigens (SLA) in BALB/c mice. Four groups of mice were immunized with S...

full text

مقایسه اثر واکسیناسیون BCG استنشاقی با تزریق زیرپوستی بر تولید نیتریک اکساید در ماکروفاژها و میزان نهفتگی انگل در بدن موش BALB/c آلوده به لیشمانیا ماژور

  Objective: In this research, the effect of intranasal and subcutaneous BCG vaccination was compared on nitric oxide production by peritoneal macrophages and the load of parasite burden in liver and spleen of infected BALB/c mice.   Materials & Methods: Twenty male 6-8 weeks old BALB/c mice were vaccinated with appropriate dose of BCG through intranasal and subcutaneous routs. They received au...

full text

Subcutaneous immunization against Leishmania major - infection in mice: efficacy of formalin-killed promastigotes combined with adjuvants.

Formalin-killed promastigotes (FKP) of Leishmania major, in combination with Montanide ISA 720 (MISA), BCG or alum were used in vaccination of an inbred murine model against cutaneous leishmaniasis (CL). Significant and specific increases in anti-FKP IgG responses were detected for both alum-FKP and BCG-FKP compared to MISA-FKP (p < 0.001). Significant increases in splenic lymphocyte recall pro...

full text

role of imiquimod as adjuvant for vaccination against leishmania major infection in balb/c mice

various adjuvants in combination with different antigens have been utilized as a vaccine candidate against leishmaniasis. however, the search for ideal adjuvants is still pursued due to the inefficiencies of current compounds. in the present study, the effect of imiquimod, as an adjuvant, is studied with soluble leishmania antigens (sla) in balb/c mice. four groups of mice were immunized with s...

full text

[BCG vaccine against tuberculosis: its protective effect and vaccination policies].

OBJECTIVE The BCG vaccine has been in use since 1921, but still arouses controversy and uncertainties. The objective was to analyze the protective effect of the BCG vaccine in its first and second doses and the accompanying vaccination policies. METHODS A systematic review of the literature in both English and Spanish was carried out, covering the period 1948 to 2006, using the PubMed databas...

full text

Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major.

The potential of Leishmania major culture-derived soluble exogenous antigens (SEAgs) to induce a protective response in susceptible BALB/c mice challenged with L. major promastigotes was investigated. Groups of BALB/c mice were immunized with L. major SEAgs alone, L. major SEAgs coadministered with either alum (aluminum hydroxide gel) or recombinant murine interleukin-12 (rmIL-12), L. major SEA...

full text

My Resources

Save resource for easier access later


Journal title:
cell journal

جلد ۸، شماره ۴، صفحات ۲۳۸-۲۴۵

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023